The court approved two opioid-class-action settlements with Purdue Canada and Roxane, and certified the Canadian Governments class for settlement purposes only.
The court allowed British Columbia to further amend its opioid-cost recovery claim, dismissed most strike applications, and permitted Noramco to be added as a defendant.
The court found the defendant liable for a head-on collision after rejecting the black-ice defence, then awarded damages for pain, loss of earnings, care, and expenses.
The Court fixed costs at $237,332.50 all inclusive because the appeals were complex and high stakes, the Crown reasonably incurred the claimed costs responding to five related but distinct appeals, there is no general $100,000 ceiling for appellate costs, and it was appropriate to apportion costs 75% to the BAT appellants and 25% to the RJR appellants payable jointly and severally by each group.